Tisento Therapeutics Funding: $81M Raised, Series A (2023)
Tisento Therapeutics is a Biotech company based in Boston, MA. It has raised $81M in total funding. Latest round: Series A.
Tisento Therapeutics funding overview
Tisento Therapeutics is a Biotech company based in Boston, MA. Tisento Therapeutics has raised $81M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2023. The round record for Tisento Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Polaris, Invus, Sanofi Ventures, Venrock. 4 distinct backers are named across the disclosed rounds.
Tisento Therapeutics at a glance
Total raised
$81M
Latest round
Series A
Latest round date
March 2023
Industry
Biotech
Headquarters
Boston, MA
Notable investors
Polaris, Invus, Sanofi Ventures, Venrock
Frequently asked about Tisento Therapeutics funding
How much has Tisento Therapeutics raised?
Tisento Therapeutics has raised $81M in total disclosed funding across the rounds on record.
Who has invested in Tisento Therapeutics?
Polaris, Invus, Sanofi Ventures, Venrock are named among the investors backing Tisento Therapeutics.
What was the latest Tisento Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2023.
Where is Tisento Therapeutics based?
Tisento Therapeutics is based in Boston, MA.
What sector does Tisento Therapeutics operate in?
Tisento Therapeutics is tracked under Biotech from Boston, MA, with $81M in disclosed funding.
When did Tisento Therapeutics last raise?
The last disclosed Tisento Therapeutics round closed in March 2023 at Series A.
Round data for Tisento Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Boston and backer lists below.
